Southwest Airlines Co. 2024 Investor Day
Southwest Airlines Co. 2024 Investor Day
PR Newswire
DALLAS, Sept. 25, 2024
DALLAS, Sept. 25, 2024 /PRNewswire/ -- Southwest Airlines Co. (NYSE: LUV) invites you to listen to a live webcast of its 2024 Investor Day. Southwest will be webcasting the presentation live, and a link to the webcast will be made available via the Investor Relations homepage on the Southwest Airlines website. Details of the webcast are as follows:
Date: | Thursday, September 26, 2024 |
Time: | 10:30 a.m. ET |
Speakers: | Bob Jordan, President, Chief Executive Officer, and Vice Chairman of the Board of Directors |
Andrew Watterson, Chief Operating Officer | |
Ryan Green, Executive Vice President Commercial Transformation | |
Tammy Romo, Executive Vice President and Chief Financial Officer | |
Web Address: |
To access the live webcast and subsequent replay, click on the link above, or go to www.southwest.com and click on "Investor Relations" under the "About Southwest" menu at the bottom of the page. The webcast can be found under "News & Events" in the drop down menu. Registration begins 20 minutes prior to the start of this event.
View original content:https://www.prnewswire.com/news-releases/southwest-airlines-co-2024-investor-day-302253827.html
SOURCE Southwest Airlines Co.
-
6 Top-Performing Large-Growth Funds
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks